GALVUS cpr 50 mg 112 pce
7680578340031
CH-57834
A10BH02
07.06.2.
Reimbursement limitations:
GALVUS4
Pour le traitement des patients diabétiques de type 2, lorsque un régime alimentaire et une …
1 / 3
google
Details
- Product number
- 5783401
- CPT
- -
- Packaging group
- 112
- Unit
- Tablette(n)
- Composition
- vildagliptinum 50.0 mg, cellulosum microcristallinum, lactosum 47.82 mg, carboxymethylamylum natricum A corresp. natrium max. 0.3 mg, magnesii stearas, pro compresso.
Articles (1)
Galvus 50 mg, Tabletten
Tabletten
112
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
47.82 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 72.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2008
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 57834
- Drug name
- Galvus, Tabletten
- Galenic form
- TAB
- ATC Code
- A10BH02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 30/04/2008
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GALVUS cpr 50 mg 112 pce
- Description (DE)
- GALVUS Tabl 50 mg 112 Stk
- Market launch
- 30/04/2008
- Narcotic (BTM)
- No